Onco-Life Cancer Centre

What Onco-Life Cancer Centre does

Onco-Life Cancer Centre is a private, founder-led chain of dedicated oncology hospitals headquartered in Satara, Maharashtra, India. Founded in 2014 by Uday Deshmukh — a radiation oncology veteran with 45+ years of experience — the company operates four wholly-owned centres across Maharashtra (Satara, Chiplun, Talegaon Dabhade, and Wagholi/Pune) with 400+ beds, making it Maharashtra's largest chain of dedicated cancer hospitals. It serves individual cancer patients across solid tumours and haematological malignancies, with explicit focus on rural and semi-urban populations that previously had limited access to advanced oncology.

The company's core offerings span radiation oncology (IMRT, IGRT, VMAT, SBRT, helical Tomotherapy with Synchrony, and Varian GAMMAMEDPLUS IX Brachytherapy), surgical oncology (including breast-conserving and reconstructive procedures), medical oncology (chemotherapy, targeted therapy, immunotherapy, hormone therapy), diagnostic imaging (PET-CT, mammography, AI-powered NIRAMAI Thermalytix thermal screening), pathology, and clinical haematology. A Virtual Tumour Board, affiliated with Tata Memorial Hospital under the National Cancer Grid, enables multi-disciplinary case review. The technology stack is largely off-the-shelf, capital-intensive medical equipment plus one third-party AI screening tool, with no proprietary AI/ML IP disclosed.

Commercially, Onco-Life generates revenue from medical, diagnostic, and pharmacy services delivered across its centres. Pricing is quote-based and not publicly disclosed, varying by cancer type, stage, modality, and room category. Payment flows are diversified across out-of-pocket patients, empanelled private insurers (Star Health, ICICI Lombard, HDFC Ergo, Niva Bupa, Tata AIG, Bajaj Allianz, Chola MS, and others) processed via an in-house TPA desk, and government schemes (MJPJAY, Ayushman Bharat, CGHS, ESIC) that provide cashless coverage up to ₹1.5 lakh per family annually. Growth has been organic and self-funded, with no disclosed equity or debt funding rounds, no parent company, and no M&A activity to date. Patient acquisition combines doctor referrals, self-referrals, community outreach (mobile screening vans, early detection camps), insurance/TPA channels, and word-of-mouth.

Name

Onco-Life Cancer Centre

Legal name

Onco-Life Cancer Centre

Website

https://oncolifehospitals.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

51–100 employees

Short description

Onco-Life Cancer Centre is Maharashtra's largest chain of dedicated oncology hospitals, operating four NABH-accredited centres across Satara, Chiplun, Talegaon, and Wagholi (Pune) with 400+ beds. It delivers radiation, surgical, medical, and diagnostic oncology plus clinical haematology to individual cancer patients, including rural and government-scheme-covered populations.

Ownership category

akta.pro rank

Product category

Cancer Hospital Services (Oncology)

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Medical and Diagnostic Laboratories (62151), Diagnostic Imaging Centers (621512)

SIC

Services-Hospitals (8060), Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

akta.pro secondary industries

Medical Oncology (HLAKAFAB), Surgical Oncology (HLAKAFAG)

Keywords

• Oncology hospital services
• Cancer treatment
• Radiation therapy
• Medical oncology
• Cancer diagnostics

Headquarters

HQ city

Satara

HQ country

India

HQ region

Asia

Offices4 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations, Supply Chain, Marketing or Sales

Revenue model

1. Medical Services Revenue: Revenue generated from comprehensive cancer treatment services including consultations, diagnostics, radiation therapy, chemotherapy, immunotherapy, surgical oncology, and inpatient care across all hospital facilities
2. TPA and Insurance Processing: Revenue from processing insurance claims and cashless treatment facilities through empanelled insurance companies and government schemes including MJPJAY, Ayushman Bharat, CGHS, ESIC
3. Diagnostic Services: Revenue from PET-CT scans, pathology, radiology, mammography, and other diagnostic imaging services
4. Pharmacy Services: Revenue from in-house 24x7 oncology pharmacy providing chemotherapy drugs, pain relief, antibiotics, and supportive care medications

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

Onco-Life Cancer Centre operates a multi-centre network of dedicated oncology hospitals in Maharashtra providing comprehensive cancer diagnostic, treatment, and care services including radiation oncology, surgical oncology, medical oncology, PET/CT imaging, pathology, hematology, and palliative care. The organization delivers precision oncology across 400+ beds at facilities in Satara, Chiplun, Talegaon, and Wagholi (Pune), supported by AI-powered screening, advanced radiation therapy modalities, a Virtual Tumour Board, and insurance/government scheme empanelment.

Product overview

Onco-Life Cancer Centre (also known as Onco-Life Hospitals) is Maharashtra's largest chain of dedicated oncology hospitals offering comprehensive cancer care through a multi-centre network across Chiplun, Satara, Talegaon, and Wagholi (Pune). The organization operates as a unified healthcare platform providing a full spectrum of oncology services including Radiation Oncology (IMRT, IGRT, VMAT, SBRT, Tomotherapy), Surgical Oncology, Medical Oncology (chemotherapy, targeted therapy, immunotherapy, hormone therapy), PET/CT imaging, Brachytherapy, Clinical Hematology, Pathology services, and specialized Breast Cancer care units. The portfolio includes diagnostic technologies like NIRAMAI Thermalytix for AI-powered breast screening and consultation services such as the Virtual Tumour Board connecting local cases with Tata Memorial Hospital experts. Support services include TPA/insurance coordination, palliative care, and government scheme empanelments (MJPJAY, Ayushman Bharat). With 400+ beds across three NABH-accredited facilities, the organization delivers personalized, multi-disciplinary cancer treatment under one roof.

Differentiator

Problem solved

Functional benefit

Products and services

• Radiation Oncology Advanced radiation therapy services including IMRT, IGRT, VMAT, SBRT, and Tomotherapy for precise cancer treatment delivery, designed for cancer patients requiring radiation-based oncology treatment.
• Surgical Oncology Cancer surgery services including breast-conserving surgeries, reconstructive procedures, and minimally invasive techniques, designed for cancer patients requiring surgical tumor removal.
• Medical Oncology Systemic cancer treatment including chemotherapy, targeted therapy, immunotherapy, and hormone therapy for patients requiring non-surgical cancer treatment.
• PET/CT Scan Advanced nuclear medicine imaging combining PET and CT technologies for cancer detection, staging, and treatment monitoring, for patients requiring diagnostic imaging.
• Brachytherapy Internal radiation therapy delivering high-dose radiation directly to tumors using sealed radioactive sources placed inside or near the cancerous area, for patients requiring localized internal radiation.
• Onco-Life Pathology Clinical pathology services including hematology, clinical chemistry, microbiology, immunopathology, cytology, and histopathology for cancer diagnosis and monitoring, for oncologists and patients requiring diagnostic confirmation.
• Clinical Hematology Specialized care for blood disorders including anemia, thalassemia, sickle cell disease, leukemia, lymphoma, myeloma, and clotting disorders, for patients with hematological malignancies and blood disorders.
• Breast Cancer Specialty Unit Comprehensive breast cancer care including early detection, mammography, 3D ultrasound, thermal screening (NIRAMAI), surgery, chemotherapy, radiation, and reconstructive surgery, for women and men diagnosed with breast cancer.
• Virtual Tumour Board Multi-specialist case review platform connecting Onco-Life oncologists with experts from Tata Memorial Hospital and other leading institutions across India via secure video conferencing, for patients with complex cancer cases requiring multi-disciplinary review.
• Immunotherapy Advanced immunotherapy treatment including checkpoint inhibitors, monoclonal antibodies, targeted immunotherapy, and combination immunotherapy for selected cancer types, for patients with cancers responsive to immune-based therapy.
• TPA & Insurance Services Third Party Administrator services facilitating cashless treatment, insurance claims processing, and coordination with major private and government insurance schemes, for insured patients seeking cashless cancer treatment.
• Additional Support Services Ancillary hospital services including 24x7 pharmacy, pain clinic, 12-bed ICU, patient family accommodation, ambulance services, nutrition counseling, psychological counseling, and transportation, for cancer patients and their families during treatment.
• Radiation Therapy (IMRT, IGRT, SBRT, SRS) Precision radiation techniques including Intensity-Modulated Radiation Therapy (IMRT), Image-Guided Radiation Therapy (IGRT), Stereotactic Body Radiation Therapy (SBRT), and Stereotactic Radiosurgery (SRS), for cancer patients requiring targeted radiation delivery.

Quantifiable outcome

• Complete regression of lymph nodes and improved voice quality by 16 weeks post-treatment for stage IVA throat cancer patients
• +1 more outcomes

Named customers5 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Six partnerships are on record, tiered core and minor.

• Tata Memorial Hospital / National Cancer Grid (NCG)coreStrategic or Co-development PartnerOnco-Life Cancer Centre is affiliated with Tata Memorial Hospital under the National Cancer Grid (NCG). This affiliation enables presentation of complex cases to top cancer experts across India through Virtual Tumour Board meetings. The partnership ensures alignment with national-level cancer treatment protocols and access to clinical trials, research updates, and new treatment advancements.
• Mahatma Jyotiba Phule Jan Arogya Yojana (MJPJAY)coreOthersGovernment of Maharashtra's flagship public health insurance scheme providing free cashless cancer treatment for low-income families. MJPJAY covers up to ₹1.5 lakh per family per year and ₹2.5 lakh for kidney transplants. The scheme covers 1,000+ procedures including chemotherapy, radiation therapy, and cancer surgeries.
• Ayushman Bharat (PMJAY)coreOthersNational health insurance scheme empanelment providing coverage for cancer treatment to eligible beneficiaries. Works alongside MJPJAY in Maharashtra to provide financial access to cancer care.
• Multiple Insurance Companies (Star Health, ICICI Lombard, HDFC Ergo, Niva Bupa, Tata AIG, Bajaj Allianz, Chola MS, Cigna TTK, and others)coreChannel Partner/ Reseller/ DistributorEmpanelled with major private insurance companies to provide cashless hospitalization for cancer treatment. TPA desk assists with claim processing, pre-authorization, and documentation for smooth cashless treatment experience.
• Panbai Welfare FoundationminorGTM or Marketing PartnerPartnership for free breast cancer screening programs using advanced NIRAMAI Thermalytix thermal imaging technology. The collaboration supports early detection and awareness campaigns for breast cancer in the community.
• CGHS and ESICminorOthersGovernment health insurance schemes supported for cancer treatment coverage including Central Government Health Scheme (CGHS) and Employees' State Insurance Corporation (ESIC).

Scale indicators7 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• Fortis Healthcare: National multi-specialty hospital chain with established oncology programs across metro and tier-2 cities. Comparable as a large private hospital group that competes for the same insured and self-pay oncology patients in Maharashtra.
• Manipal Hospitals: Multi-specialty hospital chain with growing oncology footprint, including advanced radiation therapy. Comparable as a broad incumbent expanding cancer-care services across India.
• Apollo Hospitals (Cancer Centres): Large multi-specialty hospital group with dedicated Apollo Cancer Centres across India. Comparable on advanced radiation and multi-modality oncology services, though as part of a broader hospital portfolio rather than a specialty-only operator.
• Tata Memorial Hospital: India's premier government cancer hospital and lead institution of the National Cancer Grid, with which Onco-Life is affiliated. Comparable as the gold-standard oncology provider in India and the reference center for Onco-Life's Virtual Tumour Board.
• Max Healthcare: Multi-specialty hospital chain with significant oncology programs including radiation and surgical oncology. Comparable as a large private hospital operator competing for insured and self-pay oncology patients in western India.

Direct peers

• Cytecare Cancer Hospitals: Bengaluru-based dedicated cancer hospital offering medical, surgical, and radiation oncology. Comparable as a specialty-only oncology provider with similar technology stack and multi-disciplinary tumor board approach.
• HealthCare Global Enterprises (HCG): India's largest dedicated oncology hospital network operating cancer centers across multiple states. Closest direct comparable to Onco-Life's specialty-only, multi-center cancer hospital model, with similar radiation oncology and surgical oncology service lines.
• American Oncology Institute (AOI): Multi-center dedicated oncology chain operating across India with radiation, medical, and surgical oncology services. Comparable as a specialty-only cancer hospital operator targeting tier-2 geographies and government-sponsored patients.

Regional players

• Sahyadri Hospitals: Pune-headquartered multi-specialty hospital group with oncology services competing for the same western Maharashtra catchment. Comparable as a regional incumbent operating in Onco-Life's home geography.
• Basavatarakam Indo American Cancer Hospital: Hyderabad-based dedicated cancer hospital providing multi-modality oncology care. Comparable as a regional specialty oncology provider with similar radiation and medical oncology services, though serving a different geography.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/onco_life
• YouTubeyoutube.com/@onco-lifehospitals8602
• Facebookfacebook.com/oncolifecancer
• LinkedInlinkedin.com/company/oncolife-cancer-centre
• Instagraminstagram.com/oncolifecancer

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Onco-Life Cancer Centre